 - Patient has known active CNS metastases andor carcinomatous meningitis. However, patients with CNS metastases including brain metastases who have completed a course of radiotherapy are eligible for the study provided they are clinically stable. Oral corticosteroids for control of CNS symptoms are allowed. 